Artificial intelligence is now moving from pilot projects to becoming a core layer of how hospitals operate. This episode will focus on how AI agents are being used to streamline clinical workflows, optimise hospital resources, and support safer, faster decision-making across healthcare systems. Date: 19th January 2026 Time: 9:00 PM IST | 11:30 AM

Can doctors trust artificial intelligence? Join our upcoming webinar to explore how clinicians can shape, validate, and guide AI tools that are transforming modern medicine. Hear from: Mr. Bharat Gera — AI in Healthcare: The Human Voice — Expectations, Fears, and What Works Dr. Annie Hartley — Clinician-Led AI: How Doctors Should Validate and Trust

As we transition into 2026, Medsynapse recognizes that the most significant advancements in healthcare are born from collective expertise. Medical progress is not merely an individual pursuit; it is a testament to the shared intellect, unwavering resilience, and profound professional advocacy that defines our community. Behind every clinical breakt

Introduction: Positron emission tomography/computed tomography (PET-CT) has undergone remarkable evolution over the past decade, driven by innovations in radiotracers, hybrid acquisition technologies, and image-processing tools (1). Consistent scientific efforts have expanded its diagnostic reach across oncology, inflammatory conditions, and infect

Introduction Assessing tumor response to therapy is a fundamental aspect of oncology, guiding clinical decision-making, evaluating treatment efficacy, and shaping outcomes in both routine practice and clinical trials. Tumor response assessment allows clinicians to determine whether a therapy is effective, requires adjustment, or should be discontin

In this engaging KOL (Key Opinion Leader) interview, we sit down with Dr. Dewansh Mishra, a leading DM Neuro-interventional Radiologist from Lucknow, Uttar Pradesh, to explore the complexities and evolving approaches in neurovascular care. Dr. Mishra demystifies the mechanisms, diagnosis, and modern interventional treatments for conditions such as

Introduction Gynecologic conditions often undergo biological change long before structural abnormalities appear on imaging. Early malignant transformation in the ovary, evolving endometrial irregularities, cervical microarchitectural disruption, and placental dysfunction can remain undetected on standard studies. Artificial intelligence is reshapin

Introduction Fetal magnetic resonance imaging has emerged as a powerful complementary tool to prenatal ultrasound in the evaluation of central nervous system anomalies. While ultrasound remains the first-line screening modality during pregnancy, its diagnostic performance may be limited by fetal position, maternal habitus, or acoustic shadowing. In

Introduction Liver fibrosis is a progressive condition marked by the accumulation of extracellular matrix proteins, often leading to cirrhosis and liver failure if left undiagnosed. Early detection is crucial to halt disease progression, guide treatment, and improve patient outcomes. Traditional liver biopsy, while considered the gold standard, is